2-241188700-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The ENST00000274979.12(ANO7):c.89G>A(p.Arg30Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000164 in 1,613,570 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
ENST00000274979.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANO7 | NM_001370694.2 | c.-74G>A | 5_prime_UTR_variant | 1/25 | ENST00000674324.2 | NP_001357623.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANO7 | ENST00000274979.12 | c.89G>A | p.Arg30Gln | missense_variant | 1/25 | 1 | ENSP00000274979 | P2 | ||
ANO7 | ENST00000674324.2 | c.-74G>A | 5_prime_UTR_variant | 1/25 | NM_001370694.2 | ENSP00000501393 | A2 | |||
ANO7 | ENST00000402530.8 | c.-74G>A | 5_prime_UTR_variant | 1/4 | 1 | ENSP00000383985 | ||||
ANO7 | ENST00000402430.8 | c.-74G>A | 5_prime_UTR_variant | 1/22 | 5 | ENSP00000385418 |
Frequencies
GnomAD3 genomes AF: 0.000605 AC: 92AN: 152144Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000277 AC: 69AN: 248846Hom.: 1 AF XY: 0.000289 AC XY: 39AN XY: 134870
GnomAD4 exome AF: 0.000119 AC: 174AN: 1461306Hom.: 1 Cov.: 31 AF XY: 0.000114 AC XY: 83AN XY: 726998
GnomAD4 genome AF: 0.000598 AC: 91AN: 152264Hom.: 0 Cov.: 32 AF XY: 0.000833 AC XY: 62AN XY: 74450
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at